Clinical Rheumatology

, Volume 10, Issue 4, pp 374–376

Tumour necrosis factor alpha and interleukin-2 in plasma from rheumatoid arthritis patients in relation to disease activity

  • G. T. Espersen
  • M. Vestergaard
  • E. Ernst
  • N. Grunnet
Originals

DOI: 10.1007/BF02206655

Cite this article as:
Espersen, G.T., Vestergaard, M., Ernst, E. et al. Clin Rheumatol (1991) 10: 374. doi:10.1007/BF02206655

Summary

Tumour necrosis factor alpha (TNFα) and interleukin-2 (IL-2) are potential immunological mediators of pathogenetic changes in rheumatoid arthritis. We measured the concentrations of TNFα and IL-2 in plasma from 2 groups of patients suffering from rheumatoid arthritis (RA). One group had high and one had low disease activity. In addition, in connection with steroid treatment in the high disease activity group, TNFα was significantly increased in plasma from RA patients with high disease activity compared with those of low disease activity (p=0.0009). Furthermore, TNFα decreased significantly in relation to steroid medication, parallel to clinical improvement (p=0.016). All IL-2 concentration measurements were within the estimated normal range. The increased TNFα plasma levels in patients with rheumatoid arthritis with high disease activity, might result from activated white mononuclear cells in the inflamed joints. This might, in part, support the theory that TNFα is a possible mediator of pathogenetic changes known to occur in rheumatoid arthritis.

Key words

Tumour Necrosis Factor AlphaInterleukin-2Rheumatoid Arthritis

Copyright information

© Clinical Rheumatology 1991

Authors and Affiliations

  • G. T. Espersen
    • 1
  • M. Vestergaard
    • 2
  • E. Ernst
    • 3
  • N. Grunnet
    • 1
  1. 1.Department of Clinical ImmunologyAalborg HospitalDenmark
  2. 2.Department of RheumatologyAalborg HospitalAalborgDenmark
  3. 3.Institute of AnatomyUniversity of AarhusDenmark